Intraoperative Molecular Imaging of Non-Small Cell Lung Cancer Improves Outcomes for 26 Percent of Patients in Multi-Institutional Phase 2 Clinical Trial - PRNewswire Get link Facebook X Pinterest Email Other Apps - January 27, 2020 Intraoperative Molecular Imaging of Non-Small Cell Lung Cancer Improves Outcomes for 26 Percent of Patients in Multi-Institutional Phase 2 Clinical Trial PRNewswire Get link Facebook X Pinterest Email Other Apps Comments
Comments
Post a Comment